Metabolomic and gut microbial biomarkers of smoking cessation treatment in long-term drug therapy: a study protocol for a randomized controlled trial

cbtpapertier 3link ok

Open source

ID
14e4facd403240ba
Source org
PubMed Central
Author
Johannes Peter et al.
Published
2026-03-03
OA status
gold
DOI
10.3389/fpsyt.2026.1677235
PMID
—
PMCID
PMC12984640
Citations
0

Tags

Verification

Automated checks only — not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:14e4facd403240ba,
  title = {Metabolomic and gut microbial biomarkers of smoking cessation treatment in long-term drug therapy: a study protocol for a randomized controlled trial},
  author = {Johannes Peter and Alina Pritz and Michaela Hiebler and Mahdi Mahmoudi and Jürgen Fuchshuber and Sabrina Mörkl and Sandra Holasek and Elke Humer and ­Human‐Friedrich Unterrainer},
  year = {2026},
  journal = {PubMed Central},
  doi = {10.3389/fpsyt.2026.1677235},
  url = {https://doi.org/10.3389/fpsyt.2026.1677235}
}

RIS

TY  - JOUR
TI  - Metabolomic and gut microbial biomarkers of smoking cessation treatment in long-term drug therapy: a study protocol for a randomized controlled trial
AU  - Peter, Johannes
AU  - Pritz, Alina
AU  - Hiebler, Michaela
AU  - Mahmoudi, Mahdi
AU  - Fuchshuber, Jürgen
AU  - Mörkl, Sabrina
AU  - Holasek, Sandra
AU  - Humer, Elke
AU  - Unterrainer, ­Human‐Friedrich
PY  - 2026
PB  - PubMed Central
DO  - 10.3389/fpsyt.2026.1677235
UR  - https://doi.org/10.3389/fpsyt.2026.1677235
ER  -

APA

Peter, J., Pritz, A., Hiebler, M., Mahmoudi, M., Fuchshuber, J., Mörkl, S., Holasek, S., Humer, E., & Unterrainer, ­. (2026). Metabolomic and gut microbial biomarkers of smoking cessation treatment in long-term drug therapy: a study protocol for a randomized controlled trial. PubMed Central. https://doi.org/10.3389/fpsyt.2026.1677235

Related entries